{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:36:14Z","timestamp":1793284574281,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008368","name":"The Danish Rheumatism Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008368","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004785","name":"Nordforsk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004785","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010135","name":"Finska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010135","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"Vinnova","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014034","name":"Foundation for Research in Rheumatology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014034","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["project 328657"],"award-info":[{"award-number":["project 328657"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.ard.2026.08.002","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:52:09Z","timestamp":1788580329000},"page":"2164-2173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Difficult-to-manage and treatment-refractory psoriatic arthritis in patients treated with biological and targeted synthetic DMARDs: prevalence and characteristics in 5 Nordic registries"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-2903-3058","authenticated-orcid":false,"given":"Louise Majormoen","family":"Nielung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela Di","family":"Giuseppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete Lund","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Askling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan C.","family":"Nordstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sella Aarrestad","family":"Provan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bjorn","family":"Gudbjornsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olafur","family":"Palsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Delcoigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene Wohlfahrt","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan Karlsson","family":"Wallman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-8482","authenticated-orcid":false,"given":"Bente","family":"Glintborg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ard.2026.08.002_bib0001","doi-asserted-by":"crossref","first-page":"65","DOI":"10.7861\/clinmedicine.17-1-65","article-title":"Psoriatic arthritis: state of the art review","volume":"17","author":"Coates","year":"2017","journal-title":"Clin Med (Lond)."},{"issue":"1","key":"10.1016\/j.ard.2026.08.002_bib0002","first-page":"159","article-title":"Depression and anxiety in a real-world psoriatic arthritis longitudinal study: should we focus more on patients\u2019 perception?","volume":"41","author":"Gialouri","year":"2023","journal-title":"Clin Exp Rheumatol."},{"issue":"3","key":"10.1016\/j.ard.2026.08.002_bib0003","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.semarthrit.2017.05.010","article-title":"The psychosocial burden of psoriatic arthritis","volume":"47","author":"Husni","year":"2017","journal-title":"Semin Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.ard.2026.08.002_bib0004","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1093\/rheumatology\/kez427","article-title":"Retention and response rates in 14 261 PsA patients starting TNF inhibitor treatment - results from 12 countries in EuroSpA","volume":"59","author":"Brahe","year":"2020","journal-title":"Rheumatology (Oxford)."},{"issue":"10","key":"10.1016\/j.ard.2026.08.002_bib0005","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.3899\/jrheum.190679","article-title":"Residual disease activity and associated factors in psoriatic arthritis","volume":"47","author":"Lubrano","year":"2020","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.ard.2026.08.002_bib0006","doi-asserted-by":"crossref","first-page":"839","DOI":"10.3899\/jrheum.190677","article-title":"Prevalence of psoriatic arthritis patients achieving minimal disease activity in real-world studies and randomized clinical trials: systematic review with metaanalysis","volume":"47","author":"Zardin-Moraes","year":"2020","journal-title":"J Rheumatol."},{"issue":"6","key":"10.1016\/j.ard.2026.08.002_bib0007","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/ard-2022-223650","article-title":"Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis: results from five Nordic biologics registries","volume":"82","author":"Glintborg","year":"2023","journal-title":"Ann Rheum Dis."},{"issue":"1","key":"10.1016\/j.ard.2026.08.002_bib0008","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ard.2025.10.002","article-title":"EULAR points to consider and consensus definitions for difficult-to-manage and treatment-refractory psoriatic arthritis","volume":"85","author":"Marzo-Ortega","year":"2026","journal-title":"Ann Rheum Dis."},{"issue":"5","key":"10.1016\/j.ard.2026.08.002_bib0009","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s40744-023-00574-w","article-title":"Difficult to treat and refractory to treatment in psoriatic arthritis","volume":"10","author":"Lubrano","year":"2023","journal-title":"Rheumatol Ther."},{"issue":"2","key":"10.1016\/j.ard.2026.08.002_bib0010","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41584-025-01329-3","article-title":"Consensus definitions of complex-to-manage and treatment-refractory psoriatic arthritis: a GRAPPA initiative","volume":"22","author":"Proft","year":"2026","journal-title":"Nat Rev Rheumatol."},{"key":"10.1016\/j.ard.2026.08.002_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152275","article-title":"Characteristics of difficult-to-treat psoriatic arthritis: a comparative analysis","volume":"63","author":"Philippoteaux","year":"2023","journal-title":"Semin Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.ard.2026.08.002_bib0012","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1093\/rheumatology\/keae263","article-title":"Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry","volume":"63","author":"Vassilakis","year":"2024","journal-title":"Rheumatology (Oxford)."},{"key":"10.1016\/j.ard.2026.08.002_bib0013","article-title":"Difficult-to-treat psoriatic arthritis: refining the definition using a statistical model in a real-life cohort","volume":"11","author":"Favalli","year":"2024","journal-title":"Front Med (Lausanne)."},{"issue":"4","key":"10.1016\/j.ard.2026.08.002_bib0014","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s40744-022-00461-w","article-title":"Clinical characteristics of potential \u201cdifficult-to-treat\u201d patients with psoriatic arthritis: a retrospective analysis of a longitudinal cohort","volume":"9","author":"Perrotta","year":"2022","journal-title":"Rheumatol Ther."},{"issue":"9","key":"10.1016\/j.ard.2026.08.002_bib0015","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1007\/s10067-023-06627-3","article-title":"Difficult to treat psoriatic arthritis \u2014 how should we manage?","volume":"49","author":"Kumthekar","year":"2023","journal-title":"Clin Rheumatol."},{"issue":"3","key":"10.1016\/j.ard.2026.08.002_bib0016","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/rheumatology\/keae318","article-title":"Prevalence and characteristics of adults with difficult-to-treat rheumatoid arthritis in a large patient registry","volume":"64","author":"Paudel","year":"2025","journal-title":"Rheumatology."},{"issue":"12","key":"10.1016\/j.ard.2026.08.002_bib0017","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1136\/annrheumdis-2018-213463","article-title":"Can disease activity in patients with psoriatic arthritis be adequately assessed by a modified Disease Activity index for PSoriatic Arthritis (DAPSA) based on 28 joints?","volume":"77","author":"Michelsen","year":"2018","journal-title":"Ann Rheum Dis."},{"issue":"10","key":"10.1016\/j.ard.2026.08.002_bib0018","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1002\/acr.23172","article-title":"Determinants of patient-physician discordance in global assessment in psoriatic arthritis: a multicenter European study","volume":"69","author":"Desthieux","year":"2017","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.ard.2026.08.002_bib0019","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/CLEP.S99490","article-title":"The Danish nationwide clinical register for patients with rheumatoid arthritis: DANBIO","volume":"8","author":"Ibfelt","year":"2016","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ard.2026.08.002_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2018-000655","article-title":"Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example","volume":"4","author":"Chatzidionysiou","year":"2018","journal-title":"RMD Open."},{"issue":"1","key":"10.1016\/j.ard.2026.08.002_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3109\/03009742.2014.927918","article-title":"How good is the coverage and how accurate are exposure data in the Swedish Biologics Register (ARTIS)?","volume":"44","author":"Wadstr\u00f6m","year":"2015","journal-title":"Scand J Rheumatol."},{"issue":"Suppl. 39","key":"10.1016\/j.ard.2026.08.002_bib0022","first-page":"S188","article-title":"A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases","volume":"23","author":"Kvien","year":"2005","journal-title":"Clin Exp Rheumatol."},{"issue":"5","key":"10.1016\/j.ard.2026.08.002_bib0023","first-page":"725","article-title":"Efficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practice","volume":"56","author":"Aaltonen","year":"2017","journal-title":"Rheumatology (Oxford)."},{"issue":"11","key":"10.1016\/j.ard.2026.08.002_bib0024","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/rheumatology\/keu252","article-title":"Impact of different infliximab dose regimens on treatment response and drug survival in 462 patients with psoriatic arthritis: results from the nationwide registries DANBIO and ICEBIO","volume":"53","author":"Glintborg","year":"2014","journal-title":"Rheumatology (Oxford)."},{"issue":"8","key":"10.1016\/j.ard.2026.08.002_bib0025","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol."},{"key":"10.1016\/j.ard.2026.08.002_bib0026","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol."},{"issue":"3","key":"10.1016\/j.ard.2026.08.002_bib0027","first-page":"798","article-title":"Data resource profile: the Danish national prescription registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol."},{"issue":"4","key":"10.1016\/j.ard.2026.08.002_bib0028","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"von Elm","year":"2008","journal-title":"J Clin Epidemiol."},{"key":"10.1016\/j.ard.2026.08.002_bib0029","series-title":"WHO collaborating centre for Drug Statistics Methodology [Internet]","year":"2024"},{"issue":"10","key":"10.1016\/j.ard.2026.08.002_bib0030","doi-asserted-by":"crossref","first-page":"985","DOI":"10.3899\/jrheum.2024-0101","article-title":"Difficult-to-treat concept in psoriatic arthritis: analysis of 2 potential definitions in a large group of patients: a cross-sectional study","volume":"51","author":"Perrotta","year":"2024","journal-title":"J Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.08.002_bib0031","first-page":"41","article-title":"Potential difficult-to-treat psoriatic arthritis real-world prevalence and contributing factors","volume":"43","author":"Alp","year":"2024","journal-title":"Clin Exp Rheumatol."},{"issue":"Suppl 1","key":"10.1016\/j.ard.2026.08.002_bib0032","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1136\/annrheumdis-2023-eular.3948","article-title":"AB1138 difficult-to-treat psoriatic arthritis: analysis of a single-center cohort from Northern Italy","volume":"82","author":"Cincinelli","year":"2023","journal-title":"Ann Rheum Dis."},{"issue":"9","key":"10.1016\/j.ard.2026.08.002_bib0033","doi-asserted-by":"crossref","first-page":"3799","DOI":"10.1093\/rheumatology\/keab945","article-title":"European bio-na\u00efve spondyloarthritis patients initiating TNF inhibitor: Time trends in baseline characteristics, treatment retention and response","volume":"61","author":"Christiansen","year":"2022","journal-title":"Rheumatology (Oxford)."},{"issue":"1","key":"10.1016\/j.ard.2026.08.002_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105469","article-title":"The updated GRAPPA and EULAR recommendations for the management of psoriatic arthritis: similarities and differences","volume":"90","author":"Coates","year":"2023","journal-title":"Joint Bone Spine."},{"issue":"4","key":"10.1016\/j.ard.2026.08.002_bib0035","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/art.42758","article-title":"Sex differences in the effectiveness of first-line tumor necrosis factor inhibitors in psoriatic arthritis: results from the European spondyloarthritis research collaboration network","volume":"76","author":"Hellamand","year":"2024","journal-title":"Arthritis Rheumatol."},{"issue":"4","key":"10.1016\/j.ard.2026.08.002_bib0036","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1002\/acr.23333","article-title":"Impact of comorbidities on tumor necrosis factor inhibitor therapy in psoriatic arthritis: a population-based cohort study","volume":"70","author":"Ballegaard","year":"2018","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"6","key":"10.1016\/j.ard.2026.08.002_bib0037","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/1756-185X.13553","article-title":"Systematic review of depression and anxiety in psoriatic arthritis","volume":"22","author":"Kamalaraj","year":"2019","journal-title":"Int J Rheum Dis"},{"issue":"11","key":"10.1016\/j.ard.2026.08.002_bib0038","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1136\/annrheumdis-2017-211284","article-title":"Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study","volume":"76","author":"Michelsen","year":"2017","journal-title":"Ann Rheum Dis."},{"issue":"4","key":"10.1016\/j.ard.2026.08.002_bib0039","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/rheumatology\/kep423","article-title":"Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register","volume":"49","author":"Saad","year":"2010","journal-title":"Rheumatology (Oxford)."},{"issue":"2","key":"10.1016\/j.ard.2026.08.002_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/1756-185X.13987","article-title":"Fibromyalgia in patients with psoriatic arthritis: impact on disease activity indices, fatigue and health-related quality of life","volume":"24","author":"Elsawy","year":"2021","journal-title":"Int J Rheum Dis."},{"issue":"8","key":"10.1016\/j.ard.2026.08.002_bib0041","first-page":"1453","article-title":"Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis","volume":"57","author":"Duffield","year":"2018","journal-title":"Rheumatology (Oxford)."},{"issue":"9","key":"10.1016\/j.ard.2026.08.002_bib0042","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3899\/jrheum.151491","article-title":"The effect of the presence of fibromyalgia on common clinical disease activity indices in patients with psoriatic arthritis: a cross-sectional study","volume":"43","author":"Brikman","year":"2016","journal-title":"J Rheumatol."},{"issue":"12","key":"10.1016\/j.ard.2026.08.002_bib0043","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/bcp.70177","article-title":"Trends in opioid prescribing in Scandinavian countries from 2010 to 2023: insights from multi-metric evaluation","volume":"91","author":"Rolov\u00e1","year":"2025","journal-title":"Br J Clin Pharmacol."},{"issue":"6","key":"10.1016\/j.ard.2026.08.002_bib0044","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11926-015-0517-0","article-title":"Treat to target in psoriatic arthritis\u2014evidence, target, research agenda","volume":"17","author":"Coates","year":"2015","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ard.2026.08.002_bib0045","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.42780","article-title":"Difficult-to-treat psoriatic arthritis: a conceptual approach","volume":"76","author":"Fagni","year":"2024","journal-title":"Arthritis and Rheumatology."},{"issue":"2","key":"10.1016\/j.ard.2026.08.002_bib0046","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s40744-021-00298-9","article-title":"New insights in physical therapy and rehabilitation in psoriatic arthritis: a review","volume":"8","author":"Perrotta","year":"2021","journal-title":"Rheumatol Ther."},{"issue":"4","key":"10.1016\/j.ard.2026.08.002_bib0047","article-title":"Recording of non-musculoskeletal manifestations, comorbidities and safety outcomes in European spondyloarthritis registries: a survey","volume":"8","author":"Ahmadzay","year":"2024","journal-title":"Rheumatol Adv Pract."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726004875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T14:07:49Z","timestamp":1793282869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726004875"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":47,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0003496726004875"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.08.002","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Difficult-to-manage and treatment-refractory psoriatic arthritis in patients treated with biological and targeted synthetic DMARDs: prevalence and characteristics in 5 Nordic registries","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}